Aquila Bioscience has a team of experts from a range of science diciplines, bridging Glycobiology, Immunology, Microbiology, Biochemistry and Analytical Chemistry, providing the highest quality of services and products to its customers.
Research interests lie in the fight against chronic and infectious diseases.

Biological Decontamination:

Now more than ever there is a need for non-toxic methods to disable bio-threats in urban societies. Past flu pandemics, current naturally occurring outbreak of Ebola as well as other intended and unintended

spread of pathogenic organisms and use of biotoxins require safe and effective decontamination strategies to prevent the spread. Chemical based methods such as sodium hypochloride are the most commonly used methods for the decontamination of critical infrastructure and biological surfaces; this can result in damage to the infrastructure, cellular surfaces as well as pose

environmental hazards. Civilians located in the infected areas during an attack are generally quarantined, washed with water and detergent, and then monitored for onset of symptoms. In cases where pathogens or viruses remain on human skin, water and detergent may not displace or kill the pathogen from the skin. Aquila Bioscience specializes in the science of biological adhesion. Pathogens such as bacteria and viruses enter human cells by binding to specialized sugars (glycans) and sugar binding proteins(lectins) on the surface of the cell. Aquila Bioscience uses its technologies and expertise to disrupt these interactions between pathogens and human cells by using the right combination of glycans and lectins against the pathogens. Our technologies are completely non-toxic and can even be ingested by civilians, used on open wounds, mucosal surfaces and used as a vapor in soft target areas without posing hazardous risks to nearby civilians. Aquila Bioscience was recently contracted by the European Defence Agency to develop their CBRN decontamination strategies. Our glycoscience inspired solutions are completely non-toxic and environmentally friendly.


AquilaBio News

-Jan 05th 2015: Aquila Bioscience sign contract with the European Defense Agency

-Nov 18th 2014: The Natural Product Biotechnology conference

- Oct 13th 2014: Aquila Bioscience meet with NAPES

-Sep 23rd 2014: Aquila Bioscience has been shortlisted in three categories